Exercise Plays a Crucial Role in Protecting the Brain Against Alzheimer’s Disease
Physical activity has long been known to have numerous health benefits, including reducing the risk of developing Alzheimer’s disease. A recent study on mice has delved into the specific mechanisms and proteins that explain how exercise can safeguard our brains.
Prior research had shown that exercise increases the levels of a protein called glycosylphosphatidylinositol-specific phospholipase D1 (GPLD1) in the blood of mice, which is linked to improved brain health. GPLD1 strengthens the blood-brain barrier, providing protection against inflammation and cognitive decline.
A study conducted by a team from the University of California, San Francisco (UCSF) has uncovered a connection between GPLD1 and TNAP (tissue-nonspecific alkaline phosphatase) – an enzyme that helps maintain the permeability of the blood-brain barrier during stressful conditions.
Over time, TNAP can accumulate within the cells of the blood-brain barrier, compromising its function. The study found that GPLD1 removes excess TNAP from the tissue, enhancing the barrier’s ability to protect against inflammation.
Neuroscientist Saul Villeda from UCSF emphasizes the significance of this discovery in understanding age-related brain decline, stating that the body’s role is crucial in this process.
Experiments on genetically modified mice revealed that altering TNAP levels in the blood-brain barrier affected cognitive function. Mice with increased TNAP exhibited cognitive decline similar to older mice, while reducing TNAP levels in older mice led to improved cognitive abilities.
In a mouse model of Alzheimer’s disease, higher GPLD1 levels or decreased TNAP levels were associated with reduced amyloid beta protein clumps, a hallmark of Alzheimer’s disease.
Inflammation and neuronal stress are key factors in Alzheimer’s and brain aging, with the blood-brain barrier playing a crucial role in protecting against inflammatory triggers. The study highlights the role of exercise-induced GPLD1 in maintaining a healthy blood-brain barrier and reducing the risk of cognitive decline.
Neuroscientist Gregor Bieri from UCSF emphasizes the potential of targeting this mechanism for developing future treatments, even in older age.
While the study was conducted on mice, the findings suggest similar processes may occur in humans, warranting further research in this area. Understanding these mechanisms not only sheds light on disease initiation but also offers insights into potential therapeutic strategies.
Although regular exercise may not be feasible for everyone, the study paves the way for future drug development that mimics the cognitive benefits of exercise without physical activity.
While it may take time before such drugs reach the market, the research underscores the brain-boosting effects of exercise and the potential for novel therapeutic interventions beyond conventional approaches.
The study has been published in Cell.
